Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04523181 |
|
Recruitment Status :
Completed
First Posted : August 21, 2020
Last Update Posted : January 6, 2022
|
Sponsor:
Golden Biotechnology Corporation
Information provided by (Responsible Party):
Golden Biotechnology Corporation
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 23, 2021 |
| Actual Study Completion Date : | December 23, 2021 |